Skip to main content
. Author manuscript; available in PMC: 2008 Apr 30.
Published in final edited form as: Bone. 2006 Dec 21;40(5):1276–1283. doi: 10.1016/j.bone.2006.12.053

Figure 2.

Figure 2

Recombinant IL-1 receptor antagonist significantly inhibits osteoclast differentiation induced in vitro by titanium particles. Osteoclast differentiation was assessed by measuring the number of TRAP-positive multinuclear cells/cm2. N = 5–6 for all groups.